AbCellera Biologics, Inc. (ABCL)
13.78
+0.04
(+0.29%)
USD |
NASDAQ |
Oct 05, 16:00
13.92
+0.14
(+1.05%)
Pre-Market: 08:08
AbCellera Biologics Gross Profit Margin (Quarterly) : -116.9% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -116.9% |
| March 31, 2026 | -4.09% |
| December 31, 2025 | 82.34% |
| September 30, 2025 | 19.18% |
| June 30, 2025 | 58.68% |
| March 31, 2025 | -55.96% |
| December 31, 2024 | -175.3% |
| September 30, 2024 | -488.5% |
| June 30, 2024 | -419.4% |
| March 31, 2024 | 32.03% |
| December 31, 2023 | 0.76% |
| September 30, 2023 | -12.27% |
| June 30, 2023 | 27.84% |
| Date | Value |
|---|---|
| March 31, 2023 | 0.00% |
| December 31, 2022 | 0.00% |
| September 30, 2022 | 0.00% |
| June 30, 2022 | 0.00% |
| March 31, 2022 | 0.00% |
| December 31, 2021 | 0.00% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 0.00% |
| March 31, 2021 | 0.00% |
| December 31, 2020 | 0.00% |
| September 30, 2020 | 0.00% |
| June 30, 2020 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| MindWalk Holdings Corp. | 58.58% |
| Repligen Corp. | 49.25% |
| Bio-Techne Corp. | 65.22% |
| Aurinia Pharmaceuticals, Inc. | 92.12% |
| BioLife Solutions, Inc. | 63.69% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -17.25% |
| Return on Assets | -12.23% |
| Return on Invested Capital | -15.04% |
| Profit Margin (Quarterly) | -1.37K% |
| Operating Margin (Quarterly) | -1.55K% |
| Return on Net Operating Assets | -29.68% |